HAVCR2 and ovarian carcinoma: We analyzed the expression levels of the checkpoint receptors in the three ovarian cancer subtypes responsible for decreasing T cell bioactivity, including PDCD1 (PD1), CTLA4, LAG-3, and TIM-3.